Literature DB >> 25492685

A genome-wide screen for copy number alterations in an adolescent pilot cohort with müllerian anomalies.

Jaclyn B Murry1, Xiomara M Santos2, Xiaoling Wang2, Ying-Wooi Wan2, Ignatia B Van den Veyver3, Jennifer E Dietrich4.   

Abstract

OBJECTIVE: To examine whether pathogenic copy number changes (CNCs) can be identified in deoxyribonucleic acid from females with different classes of müllerian anomalies.
DESIGN: We conducted array-based copy number variant (CNV) analysis using an oligonucleotide array from deoxyribonucleic acid in 12 adolescent females with various müllerian anomalies.
SETTING: University-affiliated tertiary care institution. PATIENT(S): Twenty adolescent females with clinically confirmed müllerian anomalies. INTERVENTION(S): Array-based CNV analysis. MAIN OUTCOME MEASURE(S): Copy number changes and/or regions with absence of heterozygosity. RESULT(S): A total of 192 CNVs identified in these samples were previously annotated as polymorphic. Three CNCs that were identified in regions with minimal to no overlap with annotated polymorphisms failed significance criteria with detailed inspection. One subject harbored a 5.1-Mb region of absence of heterozygosity at Xq23 that is of unknown significance. CONCLUSION(S): We did not identify pathogenic CNCs in this small pilot cohort of patients with various müllerian anomalies, but larger studies will be needed to further investigate whether CNCs are associated with all classes of müllerian anomalies.
Copyright © 2015 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Müllerian anomalies; absence of heterozygosity; array-based copy number analysis; copy-number change

Mesh:

Year:  2014        PMID: 25492685      PMCID: PMC4476902          DOI: 10.1016/j.fertnstert.2014.10.044

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  29 in total

1.  Clinical utility gene card for: Mayer-Rokitansky-Küster-Hauser syndrome.

Authors:  Karine Morcel; Bruno Dallapiccola; Laurent Pasquier; Tanguy Watrin; Laura Bernardini; Daniel Guerrier
Journal:  Eur J Hum Genet       Date:  2011-09-07       Impact factor: 4.246

2.  Prenatal diagnosis of chromosomal abnormalities in fetuses with abnormal cardiac ultrasound findings: evaluation of chromosomal microarray-based analysis.

Authors:  I Mademont-Soler; C Morales; A Soler; J M Martínez-Crespo; Y Shen; E Margarit; N Clusellas; M Obón; B L Wu; A Sánchez
Journal:  Ultrasound Obstet Gynecol       Date:  2013-03-04       Impact factor: 7.299

3.  Frame shift mutation of LHX1 is associated with Mayer-Rokitansky-Kuster-Hauser (MRKH) syndrome.

Authors:  S Ledig; S Brucker; G Barresi; J Schomburg; K Rall; P Wieacker
Journal:  Hum Reprod       Date:  2012-06-26       Impact factor: 6.918

4.  Chromosomal microarray versus karyotyping for prenatal diagnosis.

Authors:  Ronald J Wapner; Christa Lese Martin; Brynn Levy; Blake C Ballif; Christine M Eng; Julia M Zachary; Melissa Savage; Lawrence D Platt; Daniel Saltzman; William A Grobman; Susan Klugman; Thomas Scholl; Joe Leigh Simpson; Kimberly McCall; Vimla S Aggarwal; Brian Bunke; Odelia Nahum; Ankita Patel; Allen N Lamb; Elizabeth A Thom; Arthur L Beaudet; David H Ledbetter; Lisa G Shaffer; Laird Jackson
Journal:  N Engl J Med       Date:  2012-12-06       Impact factor: 91.245

Review 5.  New insights into the genetic basis of TAR (thrombocytopenia-absent radii) syndrome.

Authors:  Cornelis A Albers; Ruth Newbury-Ecob; Willem H Ouwehand; Cedric Ghevaert
Journal:  Curr Opin Genet Dev       Date:  2013-04-17       Impact factor: 5.578

6.  Committee Opinion No. 581: the use of chromosomal microarray analysis in prenatal diagnosis.

Authors: 
Journal:  Obstet Gynecol       Date:  2013-12       Impact factor: 7.661

7.  Chromosomal microarray testing influences medical management.

Authors:  Michael E Coulter; David T Miller; David J Harris; Pamela Hawley; Jonathan Picker; Amy E Roberts; Magdi M Sobeih; Mira Irons
Journal:  Genet Med       Date:  2011-09       Impact factor: 8.822

8.  Genotyping performance between saliva and blood-derived genomic DNAs on the DMET array: a comparison.

Authors:  Yueshan Hu; Erik A Ehli; Kelly Nelson; Krista Bohlen; Christophina Lynch; Patty Huizenga; Julie Kittlelsrud; Timothy J Soundy; Gareth E Davies
Journal:  PLoS One       Date:  2012-03-20       Impact factor: 3.240

9.  Utero-vaginal aplasia (Mayer-Rokitansky-Küster-Hauser syndrome) associated with deletions in known DiGeorge or DiGeorge-like loci.

Authors:  Karine Morcel; Tanguy Watrin; Laurent Pasquier; Lucie Rochard; Cédric Le Caignec; Christèle Dubourg; Philippe Loget; Bernard-Jean Paniel; Sylvie Odent; Véronique David; Isabelle Pellerin; Claude Bendavid; Daniel Guerrier
Journal:  Orphanet J Rare Dis       Date:  2011-03-15       Impact factor: 4.123

10.  TBX6, LHX1 and copy number variations in the complex genetics of Müllerian aplasia.

Authors:  Maria Sandbacka; Hannele Laivuori; Érika Freitas; Mervi Halttunen; Varpu Jokimaa; Laure Morin-Papunen; Carla Rosenberg; Kristiina Aittomäki
Journal:  Orphanet J Rare Dis       Date:  2013-08-16       Impact factor: 4.123

View more
  2 in total

1.  Bi-allelic truncating variants in CFAP206 cause male infertility in human and mouse.

Authors:  Qunshan Shen; Guillaume Martinez; Yunxia Cao; Charles Coutton; Hongbin Liu; Julie Beurois; Huan Wu; Amir Amiri-Yekta; Dan Liang; Zine-Eddine Kherraf; Marie Bidart; Caroline Cazin; Tristan Celse; Véronique Satre; Nicolas Thierry-Mieg; Marjorie Whitfield; Aminata Touré; Bing Song; Mingrong Lv; Kuokuo Li; Chunyu Liu; Fangbiao Tao; Xiaojin He; Feng Zhang; Christophe Arnoult; Pierre F Ray
Journal:  Hum Genet       Date:  2021-07-13       Impact factor: 4.132

Review 2.  Identification of Genetic Causes in Mayer-Rokitansky-Küster-Hauser (MRKH) Syndrome: A Systematic Review of the Literature.

Authors:  Varvara Ermioni Triantafyllidi; Despoina Mavrogianni; Andreas Kalampalikis; Michael Litos; Stella Roidi; Lina Michala
Journal:  Children (Basel)       Date:  2022-06-27
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.